Sector News

Medtronic taps virtual reality ‘flight simulators’ for brain surgery, built from 3D patient scans

May 1, 2021
Life sciences

Using virtual reality tech described as a fighter-jet flight simulator for the human body, Medtronic hopes to put brain surgeons in the pilot’s seat—giving them patient-specific maps of blood vessels and tissue to explore as they prep for the real thing.

Through a partnership with VR developer Surgical Theater, the medtech giant aims to meld real-time augmented reality technology with its StealthStation S8 surgical navigation platform used to tackle tumors, aneurysms, vessel malformations and other conditions.

The goal is to give neurosurgeons a way to test different approaches virtually before they enter the operating room—as well as to provide a live, 3D rendering, laid on top of the surgical site during brain procedures, to illustrate how close instruments are to reaching dangerous areas.

“SyncAR technology does not stop at planning and navigation; we open the skull, provide surgeons with x-ray vision of the anatomy and play an integral role throughout the operative workflow,” Surgical Theater’s co-founder and CEO, Moty Avisar, said in a statement.

The company’s team is no stranger to situational awareness: Avisar is a former officer and flight simulator expert for the Israeli Air Force, where he helped manage the engineering behind virtual training programs for F-16 fighter pilots. Co-founder and Chief Technology Officer Alon Geri served as a Black Hawk helicopter pilot and chief software engineer for the IAF’s flight simulator team.

Now, their technology builds 3D models of an individual patient’s anatomy from CT and MRI scans to offer surgeons an immersive, 360-degree view.

Medtronic aims to synchronize these tools, which have been used in more than 1,500 procedures so far, with its StealthStation navigation system and microscope-based optics to highlight important arteries and delicate white matter in a heads-up display.

The work could help complement Medtronic’s acquisition early last year of Digital Surgery, the U.K.-based developer of artificial intelligence and video education programs for the operating room. This, in turn, would dovetail with the company’s broader digital hardware and robotics efforts, including its upcoming Hugo platform.

In 2019, Medtronic’s previous CEO, Omar Ishrak, said the company would look to apply computer-guided surgery, planning tools and robotics in “virtually every area” where it has a procedural presence.

by Conor Hale

Source: fiercebiotech.com

Related News

May 1, 2021

AbbVie remains one of the best buys in its sector

Life sciences

AbbVie will be among the stocks closing out a busy earnings week. Earnings season tends to draw a lot of interest from investors, but it’s not always the best indicator of a stock’s overall trajectory.

May 1, 2021

Pfizer buys infectious disease biotech Amplyx

Life sciences

Pfizer has bought privately held Amplyx Pharmaceuticals for an undisclosed sum, gaining experimental antifungal and antiviral treatments as the world’s attention turns more toward infectious diseases.

May 1, 2021

Gene therapy ‘development engine’ scores $120M to beef up contract manufacturing

Life sciences

The self-styled gene therapy “development engine” raised $120 million to quickly expand capacity for its adeno-associated virus (AAV) contract manufacturing services—and triple its workforce along the way.

Send this to a friend